Cargando…

Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study

Features of the gut microbiota have been associated with several chronic diseases and longevity in preclinical models as well as in observational studies. Whether these relations underlie causal effects in humans remains to be established. We aimed to determine whether the gut microbiota influences...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagnon, Eloi, Mitchell, Patricia L., Manikpurage, Hasanga D., Abner, Erik, Taba, Nele, Esko, Tõnu, Ghodsian, Nooshin, Thériault, Sébastien, Mathieu, Patrick, Arsenault, Benoit J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887809/
https://www.ncbi.nlm.nih.gov/pubmed/36717893
http://dx.doi.org/10.1186/s12967-022-03799-5
_version_ 1784880411703246848
author Gagnon, Eloi
Mitchell, Patricia L.
Manikpurage, Hasanga D.
Abner, Erik
Taba, Nele
Esko, Tõnu
Ghodsian, Nooshin
Thériault, Sébastien
Mathieu, Patrick
Arsenault, Benoit J.
author_facet Gagnon, Eloi
Mitchell, Patricia L.
Manikpurage, Hasanga D.
Abner, Erik
Taba, Nele
Esko, Tõnu
Ghodsian, Nooshin
Thériault, Sébastien
Mathieu, Patrick
Arsenault, Benoit J.
author_sort Gagnon, Eloi
collection PubMed
description Features of the gut microbiota have been associated with several chronic diseases and longevity in preclinical models as well as in observational studies. Whether these relations underlie causal effects in humans remains to be established. We aimed to determine whether the gut microbiota influences cardiometabolic traits as well as the risk of chronic diseases and human longevity using a comprehensive 2-Sample Mendelian randomization approach. We included as exposures 10 gut-associated metabolites and pathways and 57 microbial taxa abundance. We included as outcomes nine cardiometabolic traits (fasting glucose, fasting insulin, systolic blood pressure, diastolic blood pressure, HDL cholesterol, LDL cholesterol, triglycerides, estimated glomerular filtration rate, body mass index [BMI]), eight chronic diseases previously linked with the gut microbiota in observational studies (Alzheimer’s disease, depression, type 2 diabetes, non-alcoholic fatty liver disease, coronary artery disease (CAD), stroke, osteoporosis and chronic kidney disease), as well as parental lifespan and longevity. We found 7 associations with evidence of causality before and after sensitivity analyses, but not after multiple testing correction (1198 tests). Most effect sizes (4/7) were small. The two largest exposure-outcome effects were markedly attenuated towards the null upon inclusion of BMI or alcohol intake frequency in multivariable MR analyses. While finding robust genetic instruments for microbiota features is challenging hence potentially inflating type 2 errors, these results do not support a large causal impact of human gut microbita features on cardiometabolic traits, chronic diseases or longevity. These results also suggest that the previously documented associations between gut microbiota and human health outcomes may not always underly causal relations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03799-5.
format Online
Article
Text
id pubmed-9887809
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98878092023-02-01 Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study Gagnon, Eloi Mitchell, Patricia L. Manikpurage, Hasanga D. Abner, Erik Taba, Nele Esko, Tõnu Ghodsian, Nooshin Thériault, Sébastien Mathieu, Patrick Arsenault, Benoit J. J Transl Med Research Features of the gut microbiota have been associated with several chronic diseases and longevity in preclinical models as well as in observational studies. Whether these relations underlie causal effects in humans remains to be established. We aimed to determine whether the gut microbiota influences cardiometabolic traits as well as the risk of chronic diseases and human longevity using a comprehensive 2-Sample Mendelian randomization approach. We included as exposures 10 gut-associated metabolites and pathways and 57 microbial taxa abundance. We included as outcomes nine cardiometabolic traits (fasting glucose, fasting insulin, systolic blood pressure, diastolic blood pressure, HDL cholesterol, LDL cholesterol, triglycerides, estimated glomerular filtration rate, body mass index [BMI]), eight chronic diseases previously linked with the gut microbiota in observational studies (Alzheimer’s disease, depression, type 2 diabetes, non-alcoholic fatty liver disease, coronary artery disease (CAD), stroke, osteoporosis and chronic kidney disease), as well as parental lifespan and longevity. We found 7 associations with evidence of causality before and after sensitivity analyses, but not after multiple testing correction (1198 tests). Most effect sizes (4/7) were small. The two largest exposure-outcome effects were markedly attenuated towards the null upon inclusion of BMI or alcohol intake frequency in multivariable MR analyses. While finding robust genetic instruments for microbiota features is challenging hence potentially inflating type 2 errors, these results do not support a large causal impact of human gut microbita features on cardiometabolic traits, chronic diseases or longevity. These results also suggest that the previously documented associations between gut microbiota and human health outcomes may not always underly causal relations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03799-5. BioMed Central 2023-01-30 /pmc/articles/PMC9887809/ /pubmed/36717893 http://dx.doi.org/10.1186/s12967-022-03799-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gagnon, Eloi
Mitchell, Patricia L.
Manikpurage, Hasanga D.
Abner, Erik
Taba, Nele
Esko, Tõnu
Ghodsian, Nooshin
Thériault, Sébastien
Mathieu, Patrick
Arsenault, Benoit J.
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
title Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
title_full Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
title_fullStr Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
title_full_unstemmed Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
title_short Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
title_sort impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a mendelian randomization study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887809/
https://www.ncbi.nlm.nih.gov/pubmed/36717893
http://dx.doi.org/10.1186/s12967-022-03799-5
work_keys_str_mv AT gagnoneloi impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT mitchellpatricial impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT manikpuragehasangad impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT abnererik impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT tabanele impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT eskotonu impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT ghodsiannooshin impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT theriaultsebastien impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT mathieupatrick impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy
AT arsenaultbenoitj impactofthegutmicrobiotaandassociatedmetabolitesoncardiometabolictraitschronicdiseasesandhumanlongevityamendelianrandomizationstudy